stella
beta
Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC — Stella
Recruiting
Back to NSCLC (Non-small Cell Lung Cancer) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Tianjin Medical University Cancer Institute and Hospital, Tianjin
View full record on ClinicalTrials.gov